ARCHIVES

Interview With Departing NCI Director; Advice To His Successor.

This article is from The Cancer Letter archive.

Vol. 36 No. 26 | July 9, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says

February 20, 1998

NCI Programs: 15 New Grants Awarded In Survivor Research

October 9, 1998

Two Reports Offer Definitions, Plans For Comparative Effectiveness Research

July 3, 2009

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 5, 1990

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002